Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma

[1]  D. Altieri,et al.  Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. , 2007, Molecular cell.

[2]  N. Willich,et al.  Multicentric investigation of ionising radiation-induced cell death as a predictive parameter of individual radiosensitivity , 2009, Apoptosis.

[3]  Chun-Peng Liao,et al.  Cancer Stem Cells and Microenvironment in Prostate Cancer Progression , 2010, Hormones & cancer.

[4]  J. Becker,et al.  Cancer treatment: the combination of vaccination with other therapies , 2008, Cancer Immunology, Immunotherapy.

[5]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[6]  Martin Götte,et al.  Flow cytometry in cancer stem cell analysis and separation , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[7]  M. Abdraboh,et al.  Survivin is a novel target of CD44-promoted breast tumor invasion. , 2011, The American journal of pathology.

[8]  Lawrence J. Sheplan,et al.  Use of radiation therapy for patients with soft-tissue and bone sarcomas , 2010, Cleveland Clinic Journal of Medicine.

[9]  J. Debus,et al.  Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation , 2012, Strahlentherapie und Onkologie.

[10]  E. Karakuş,et al.  High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer , 2012, Strahlentherapie und Onkologie.

[11]  Anne E Carpenter,et al.  CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.

[12]  R. Bataille,et al.  [Survivin in cancerology : molecular aspects and therapeutic applications]. , 2008, Medecine sciences : M/S.

[13]  D. Talbot,et al.  Survivin in Solid Tumors: Rationale for Development of Inhibitors , 2012, Current Oncology Reports.

[14]  R. Medema,et al.  The case for Survivin as mitotic regulator. , 2006, Current opinion in cell biology.

[15]  Xiao-Feng Sun,et al.  Protein expression following γ-irradiation relevant to growth arrest and apoptosis in colon cancer cells , 2009, Journal of Cancer Research and Clinical Oncology.

[16]  Patrik Langehanenberg,et al.  Label-free quantitative cell division monitoring of endothelial cells by digital holographic microscopy. , 2010, Journal of biomedical optics.

[17]  C. Rödel,et al.  Survivin inhibition and DNA double-strand break repair: a molecular mechanism to overcome radioresistance in glioblastoma. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[18]  K. Dittmann,et al.  Radiation-induced survivin nuclear accumulation is linked to DNA damage repair. , 2010, International journal of radiation oncology, biology, physics.

[19]  D. Altieri.  Survivin and apoptosis control. , 2003, Advances in cancer research.

[20]  N. Zaffaroni,et al.  Targeting survivin in cancer therapy , 2008, Expert opinion on therapeutic targets.

[21]  F. W. Bauer,et al.  A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation. , 1988, Cytometry.

[22]  Benjamin Frey,et al.  Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models. , 2008, International journal of radiation oncology, biology, physics.

[23]  Daniel Carl,et al.  Modular digital holographic microscopy system for marker free quantitative phase contrast imaging of living cells , 2006, SPIE Photonics Europe.

[24]  M. Bache,et al.  The Role of Survivin for Radiation Therapy , 2007, Strahlentherapie und Onkologie.

[25]  G. Giaccone,et al.  Multicenter phase II trial of YM155, a small-molecule suppressor of survivin, in patients with advanced, refractory, non-small-cell lung cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[27]  Yoshiyuki Suzuki,et al.  Nuclear survivin expression predicts poorer prognosis in glioblastoma , 2009, Journal of Neuro-Oncology.

[28]  A. Magalska,et al.  Curcumin Affects Components of the Chromosomal Passenger Complex and Induces Mitotic Catastrophe in Apoptosis-Resistant Bcr-Abl-Expressing Cells , 2006, Molecular Cancer Research.

[29]  H. Taubert,et al.  Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53 , 2004, Cancer Gene Therapy.

[30]  M. Fukuoka,et al.  Phase I Study of YM155, a Novel Survivin Suppressant, in Patients with Advanced Solid Tumors , 2009, Clinical Cancer Research.

[31]  Daniel Carl,et al.  Investigation of living pancreas tumor cells by digital holographic microscopy. , 2006, Journal of biomedical optics.

[32]  J. Khoury.  Ewing Sarcoma Family of Tumors , 2005, Advances in anatomic pathology.

[33]  Daniel Carl,et al.  Parameter-optimized digital holographic microscope for high-resolution living-cell analysis. , 2004, Applied optics.

[34]  M. Fukuoka,et al.  Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non–Small Cell Lung Cancer Cell Lines , 2008, Clinical Cancer Research.

[35]  John Calvin Reed,et al.  HBXIP functions as a cofactor of survivin in apoptosis suppression , 2003, The EMBO journal.

[36]  A. B. Hassan,et al.  The clinical use of biomarkers as prognostic factors in Ewing sarcoma , 2012, Clinical Sarcoma Research.

[37]  Alain C. Mita,et al.  Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics , 2008, Clinical Cancer Research.

[38]  A. Chakravarti,et al.  Survivin splice variants are not essential for mitotic progression or inhibition of apoptosis induced by doxorubicin and radiation , 2012, OncoTargets and therapy.

[39]  M. Monden,et al.  Cancer cells survive with survivin , 2008, Cancer science.

[40]  T. Beißbarth,et al.  Failure of Downregulation of Survivin Following Neoadjuvant Radiochemotherapy in Rectal Cancer Is Associated with Distant Metastases and Shortened Survival , 2010, Clinical Cancer Research.

[41]  C. Rödel,et al.  Survivin expression as a predictive marker for local control in patients with high-risk T1 bladder cancer treated with transurethral resection and radiochemotherapy. , 2009, International journal of radiation oncology, biology, physics.